Enlightening Session with Sam Tomlinson, Vice President of Global Drug Safety at Arriello.
As biotechnology continues to rapidly transform the medical and healthcare realms, Pharmacovigilance finds itself challenged to match the speed of innovation in assessing the safety of emerging products entering the market and that too when they undergo continuous refinement. How to address this issue was the central theme of a